Spark Investment Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Spark Investment Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-134,600	Closed	-$4.05M	–	574
2019 Q2	$4.05M	Sell	134,600 -19,800	-13%	-$454K	0.28%	113
2019 Q1	$3.46M	Buy	+154,400	New	+$3.32M	0.16%	176
2018 Q1	–	Sell	-39,600	Closed	-$336K	–	792
2017 Q4	$336K	Buy	39,600 +7,600	+24%	+$93.5K	0.02%	509
2017 Q3	$467K	Sell	32,000 -25,400	-44%	-$384K	0.03%	494
2017 Q2	$1.07M	Buy	57,400 +24,500	+74%	+$553K	0.07%	371
2017 Q1	$700K	Buy	+32,900	New	+$629K	0.04%	474

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Spark Investment Management's RARX Position: Q3 2019 in Review

Spark Investment Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q3 2019, closing a stake of 134,600 shares — an estimated $4.05M sold.

Spark Investment Management first reported a position in RARX in Q1 2017 and held it in 6 quarters. The position peaked at $4.05M in Q2 2019. 119 funds tracked by Wall St. Rank hold RARX as of Q3 2019.

Spark Investment Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Spark Investment Management sold 134,600 Ra Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $4.05M.
Spark Investment Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 6 quarters.
Spark Investment Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $4.05M in Q2 2019.
119 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.